{"title":"记忆评估量表:基于人群的认知障碍筛查工具。","authors":"William T Tsushima, Justin R Abe, Andrea M Siu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This study re-examined the Memory Assessment Scale (MAS), a brief memory test developed in Hawai'i in 1987, to assess whether it remains a valid and reliable cognitive impairment screening tool in Hawai'i. Patients suspected of having neurocognitive dysfunction were divided into 2 groups (those with and without mild cognitive impairment) based on their results on a battery of neuropsychological tests. No differences in MAS scores were found between patients with and without mild cognitive impairment. Further research with the MAS comparing patients with mild cognitive disorder to healthy controls is indicated to further examine the efficacy of this population-based test.</p>","PeriodicalId":36659,"journal":{"name":"Hawai''i journal of health & social welfare","volume":"83 3","pages":"75-80"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10915864/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Memory Assessment Scale: A Population-based Cognitive Impairment Screening Instrument.\",\"authors\":\"William T Tsushima, Justin R Abe, Andrea M Siu\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study re-examined the Memory Assessment Scale (MAS), a brief memory test developed in Hawai'i in 1987, to assess whether it remains a valid and reliable cognitive impairment screening tool in Hawai'i. Patients suspected of having neurocognitive dysfunction were divided into 2 groups (those with and without mild cognitive impairment) based on their results on a battery of neuropsychological tests. No differences in MAS scores were found between patients with and without mild cognitive impairment. Further research with the MAS comparing patients with mild cognitive disorder to healthy controls is indicated to further examine the efficacy of this population-based test.</p>\",\"PeriodicalId\":36659,\"journal\":{\"name\":\"Hawai''i journal of health & social welfare\",\"volume\":\"83 3\",\"pages\":\"75-80\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10915864/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hawai''i journal of health & social welfare\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hawai''i journal of health & social welfare","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
记忆评估量表(Memory Assessment Scale,MAS)是夏威夷于 1987 年开发的一种简短记忆测试,本研究对该量表进行了重新审查,以评估它在夏威夷是否仍然是一种有效、可靠的认知功能障碍筛查工具。根据一系列神经心理测试的结果,疑似神经认知功能障碍患者被分为两组(有轻度认知功能障碍和无轻度认知功能障碍)。结果发现,有轻度认知障碍和没有轻度认知障碍的患者在 MAS 分数上没有差异。我们建议对轻度认知障碍患者和健康对照组的 MAS 进行进一步研究,以进一步检验这种基于人群的测试的有效性。
The Memory Assessment Scale: A Population-based Cognitive Impairment Screening Instrument.
This study re-examined the Memory Assessment Scale (MAS), a brief memory test developed in Hawai'i in 1987, to assess whether it remains a valid and reliable cognitive impairment screening tool in Hawai'i. Patients suspected of having neurocognitive dysfunction were divided into 2 groups (those with and without mild cognitive impairment) based on their results on a battery of neuropsychological tests. No differences in MAS scores were found between patients with and without mild cognitive impairment. Further research with the MAS comparing patients with mild cognitive disorder to healthy controls is indicated to further examine the efficacy of this population-based test.